[HTML][HTML] A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor γ deficiency

CR Walkley, GH Olsen, S Dworkin, SA Fabb, J Swann… - Cell, 2007 - cell.com
CR Walkley, GH Olsen, S Dworkin, SA Fabb, J Swann, GA McArthur, SV Westmoreland…
Cell, 2007cell.com
Myeloproliferative syndromes (MPS) are a heterogeneous subclass of nonlymphoid
hematopoietic neoplasms which are considered to be intrinsic to hematopoietic cells. The
causes of MPS are largely unknown. Here, we demonstrate that mice deficient for retinoic
acid receptor γ (RARγ), develop MPS induced solely by the RARγ-deficient
microenvironment. RARγ−/− mice had significantly increased granulocyte/macrophage
progenitors and granulocytes in bone marrow (BM), peripheral blood, and spleen. The MPS …
Summary
Myeloproliferative syndromes (MPS) are a heterogeneous subclass of nonlymphoid hematopoietic neoplasms which are considered to be intrinsic to hematopoietic cells. The causes of MPS are largely unknown. Here, we demonstrate that mice deficient for retinoic acid receptor γ (RARγ), develop MPS induced solely by the RARγ-deficient microenvironment. RARγ−/− mice had significantly increased granulocyte/macrophage progenitors and granulocytes in bone marrow (BM), peripheral blood, and spleen. The MPS phenotype continued for the lifespan of the mice and was more pronounced in older mice. Unexpectedly, transplant studies revealed this disease was not intrinsic to the hematopoietic cells. BM from wild-type mice transplanted into mice with an RARγ−/− microenvironment rapidly developed the MPS, which was partially caused by significantly elevated TNFα in RARγ−/− mice. These data show that loss of RARγ results in a nonhematopoietic cell-intrinsic MPS, revealing the capability of the microenvironment to be the sole cause of hematopoietic disorders.
cell.com